High-quality CMV-specific

American Journal of Transplantation

Volumn 13, Issue 1, 2013, Pages 146-156

  Akulian, J A ^a   Pipeling, M R ^a   John, E R ^a   Orens, J B ^a   Lechtzin, N ^a   McDyer, J F ^a,b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

CMV; lung transplant; memory; T cells; viral control

Indexed keywords

CYTOMEGALOVIRUS ANTIGEN PP65; GAMMA INTERFERON; INTERLEUKIN 2; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ALLOGRAFT; ANTIGEN SPECIFICITY; ARTICLE; CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; EFFECTOR CELL; FEMALE; GRAFT RECIPIENT; HUMAN; HUMAN CELL; LUNG LAVAGE; LUNG TRANSPLANTATION; MALE; MEMORY T LYMPHOCYTE; MONONUCLEAR CELL; MUCOSAL IMMUNITY; ORGAN DONOR; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIMARY INFECTION; PRIORITY JOURNAL; PROSPECTIVE STUDY;

ADULT; BRONCHOALVEOLAR LAVAGE FLUID; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNITY, MUCOSAL; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84871717995     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2012.04282.x     Document Type: Article

References (53)

1. Ljungman P,. Beta-herpesvirus challenges in the transplant recipient. J Infect Dis 2002; 186 Suppl 1: S99-S109.
2. Pereyra F, Rubin RH,. Prevention and treatment of cytomegalovirus infection in solid organ transplant recipients. Curr Opin Infect Dis. 2004; 17: 357-361.
3. Fishman JA,. Infection in solid-organ transplant recipients. N Engl J Med 2007; 357: 2601-2614.
4. Zamora MR,. Cytomegalovirus and lung transplantation. Am J Transplant 2004; 4: 1219-1226.
5. Christie JD, Edwards LB, Kucheryavaya AY, et al.. The Registry of the International Society for Heart and Lung Transplantation: Twenty-seventh official adult lung and heart-lung transplant report-2010. J Heart Lung Transplant 2010; 29: 1104-1118.
6. Westall GP, Michaelides A, Williams TJ, Snell GI, Kotsimbos TC,. Bronchiolitis obliterans syndrome and early human cytomegalovirus DNAaemia dynamics after lung transplantation. Transplantation 2003; 75: 2064-2068.
7. Snyder LD, Finlen-Copeland CA, Turbyfill WJ, Howell D, Willner DA, Palmer SM,. Cytomegalovirus pneumonitis is a risk for bronchiolitis obliterans syndrome in lung transplantation. Am J Respir Crit Care Med 2010; 181: 1391-1396.
8. Kerschner H, Jaksch P, Karigl G, Popow-Kraupp T, Klepetko W, Puchhammer-Stockl E,. Cytomegalovirus DNA load patterns developing after lung transplantation are significantly correlated with long-term patient survival. Transplantation 2009; 87: 1720-1726.
9. Shlobin OA, West EE, Lechtzin N, et al.. Persistent cytomegalovirus- specific memory responses in the lung allograft and blood following primary infection in lung transplant recipients. J Immunol 2006; 176: 2625-2634.
10. Pipeling MR, West EE, Osborne CM, et al.. Differential CMV-specific CD8+ effector T cell responses in the lung allograft predominate over the blood during human primary infection. J Immunol 2008; 181: 546-556.
11. Seder RA, Darrah PA, Roederer M,. T-cell quality in memory and protection: Implications for vaccine design. Nat Rev Immunol 2008; 8: 247-258.
12. Sund F, Lidehall AK, Claesson K, et al.. CMV-specific T-cell immunity, viral load, and clinical outcome in seropositive renal transplant recipients: a pilot study. Clin Transplant 2010; 24: 401-409.
13. Jagannathan P, Osborne CM, Royce C, et al.. Comparisons of CD8+ T cells specific for human immunodeficiency virus, hepatitis C virus, and cytomegalovirus reveal differences in frequency, immunodominance, phenotype, and interleukin-2 responsiveness. J Virol 2009; 83: 2728-2742.
14. Roederer M, Nozzi JL, Nason MC,. SPICE: Exploration and analysis of post-cytometric complex multivariate datasets. Cytometry A 2011; 79: 167-174.
15. Humar A, Michaels M,. American Society of Transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation. Am J Transplant 2006; 6: 262-274.
16. Maecker HT, Ghanekar SA, Suni MA, He XS, Picker LJ, Maino VC,. Factors affecting the efficiency of CD8+ T cell cross-priming with exogenous antigens. J Immunol 2001; 166: 7268-7275.
17. Darrah PA, Patel DT, De Luca PM, et al.. Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major. Nat Med 2007; 13: 843-850.
18. Kannanganat S, Ibegbu C, Chennareddi L, Robinson HL, Amara RR,. Multiple-cytokine-producing antiviral CD4 T cells are functionally superior to single-cytokine-producing cells. J Virol 2007; 81: 8468-8476.
19. Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A,. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999; 401: 708-712.
20. Lucin P, Pavic I, Polic B, Jonjic S, Koszinowski UH,. Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands. J Virol 1992; 66: 1977-1984.
21. Walton SM, Wyrsch P, Munks MW, et al.. The dynamics of mouse cytomegalovirus-specific CD4 T cell responses during acute and latent infection. J Immunol 2008; 181: 1128-1134.
22. Arens R, Wang P, Sidney J, et al.. Cutting edge: Murine cytomegalovirus induces a polyfunctional CD4 T cell response. J Immunol 2008; 180: 6472-6476.
23. Balthesen M, Messerle M, Reddehase MJ,. Lungs are a major organ site of cytomegalovirus latency and recurrence. J Virol 1993; 67: 5360-5366.
24. Reinhardt RL, Khoruts A, Merica R, Zell T, Jenkins MK,. Visualizing the generation of memory CD4 T cells in the whole body. Nature 2001; 410: 101-105.
25. Masopust D, Vezys V, Marzo AL, Lefrancois L,. Preferential localization of effector memory cells in nonlymphoid tissue. Science 2001; 291: 2413-2417.
26. Brenchley JM, Knox KS, Asher AI, et al.. High frequencies of polyfunctional HIV-specific T cells are associated with preservation of mucosal CD4 T cells in bronchoalveolar lavage. Mucosal Immunol 2008; 1: 49-58.
27. de Bree GJ, van Leeuwen EM, Out TA, Jansen HM, Jonkers RE, van Lier RA,. Selective accumulation of differentiated CD8+ T cells specific for respiratory viruses in the human lung. J Exp Med 2005; 202: 1433-1442.
28. Ely KH, Cookenham T, Roberts AD, Woodland DL,. Memory T cell populations in the lung airways are maintained by continual recruitment. J Immunol 2006; 176: 537-543.
29. Roberts AD, Woodland DL,. Cutting edge: Effector memory CD8+ T cells play a prominent role in recall responses to secondary viral infection in the lung. J Immunol 2004; 172: 6533-6537.
30. Masopust D, Vezys V, Usherwood EJ, et al.. Activated primary and memory CD8 T cells migrate to nonlymphoid tissues regardless of site of activation or tissue of origin. J Immunol 2004; 172: 4875-4882.
31. Kohlmeier JE, Miller SC, Woodland DL,. Cutting edge: Antigen is not required for the activation and maintenance of virus-specific memory CD8+ T cells in the lung airways. J Immunol 2007; 178: 4721-4725.
32. Sandberg JK, Fast NM, Jordan KA, et al.. HIV-specific CD8+ T cell function in children with vertically acquired HIV-1 infection is critically influenced by age and the state of the CD4+ T cell compartment. J Immunol 2003; 170: 4403-4410.
33. Seddon B, Tomlinson P, Zamoyska R,. Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat Immunol 2003; 4: 680-686.
34. Kassiotis G, Garcia S, Simpson E, Stockinger B,. Impairment of immunological memory in the absence of MHC despite survival of memory T cells. Nat Immunol 2002; 3: 244-250.
35. Lees JR, Farber DL,. Generation, persistence and plasticity of CD4 T-cell memories. Immunology 2010; 130: 463-470.
36. Kondrack RM, Harbertson J, Tan JT, McBreen ME, Surh CD, Bradley LM,. Interleukin 7 regulates the survival and generation of memory CD4 cells. J Exp Med 2003; 198: 1797-1806.
37. Purton JF, Tan JT, Rubinstein MP, Kim DM, Sprent J, Surh CD,. Antiviral CD4 +memory T cells are IL-15 dependent. J Exp Med 2007; 204: 951-961.
38. van Leeuwen EM, Gamadia LE, Baars PA, Remmerswaal EB, ten Berge IJ, van Lier RA,. Proliferation requirements of cytomegalovirus-specific, effector-type human CD8+ T cells. J Immunol 2002; 169: 5838-5843.
39. Harris NL, Watt V, Ronchese F, Le Gros G,. Differential T cell function and fate in lymph node and nonlymphoid tissues. J Exp Med 2002; 195: 317-326.
40. Millington KA, Innes JA, Hackforth S, et al.. Dynamic relationship between IFN-gamma and IL-2 profile of mycobacterium tuberculosis-specific T cells and antigen load. J Immunol 2007; 178: 5217-5226.
41. Tilton JC, Luskin MR, Johnson AJ, et al.. Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load. J Virol 2007; 81: 2713-2725.
42. Casazza JP, Brenchley JM, Hill BJ, et al.. Autocrine production of beta-chemokines protects CMV-Specific CD4 T cells from HIV infection. PLoS Pathog 2009; 5: e1000646.
43. Wu CY, Kirman JR, Rotte MJ, et al.. Distinct lineages of T(H)1 cells have differential capacities for memory cell generation in vivo. Nat Immunol 2002; 3: 852-858.
44. Harrington LE, Janowski KM, Oliver JR, Zajac AJ, Weaver CT,. Memory CD4 T cells emerge from effector T-cell progenitors. Nature 2008; 452: 356-360.
45. Chang JT, Palanivel VR, Kinjyo I, et al.. Asymmetric T lymphocyte division in the initiation of adaptive immune responses. Science 2007; 315: 1687-1691.
46. Chang JT, Ciocca ML, Kinjyo I, et al.. Asymmetric proteasome segregation as a mechanism for unequal partitioning of the transcription factor T-bet during T lymphocyte division. Immunity 2011; 34: 492-504.
47. Appay V, Dunbar PR, Callan M, et al.. Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections. Nat Med 2002; 8: 379-385.
48. Roos MT, van Lier RA, Hamann D, et al.. Changes in the composition of circulating CD8+ T cell subsets during acute Epstein-Barr and human immunodeficiency virus infections in humans. J Infect Dis 2000; 182: 451-458.
49. Kern F, Bunde T, Faulhaber N, et al.. Cytomegalovirus (CMV) phosphoprotein 65 makes a large contribution to shaping the T cell repertoire in CMV-exposed individuals. J Infect Dis 2002; 185: 1709-1716.
50. Sylwester AW, Mitchell BL, Edgar JB, et al.. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 2005; 202: 673-685.
51. Migueles SA, Weeks KA, Nou E, et al.. Defective human immunodeficiency virus-specific CD8+ T-cell polyfunctionality, proliferation, and cytotoxicity are not restored by antiretroviral therapy. J Virol 2009; 83: 11876-11889.
52. Bunde T, Kirchner A, Hoffmeister B, et al.. Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J Exp Med 2005; 201: 1031-1036.
53. Pipeling MR, John ER, Orens JB, Lechtzin N, McDyer JF,. Primary cytomegalovirus phosphoprotein 65-specific CD8+ T-cell responses and T-bet levels predict immune control during early chronic infection in lung transplant recipients. J Infect Dis 2011; 204: 1663-1671.